Related Experiment Video
Updated: Jan 15, 2026

Evaluation of Respiratory Muscle Activation Using Respiratory Motor Control Assessment RMCA in Individuals with Chronic Spinal Cord Injury
Published on: July 19, 2013
The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): results of a randomized
Kim Kant-Smits1, Bart Bartels1, Ruben P A van Eijk2
1Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.
Objectives:
To investigate the efficacy and feasibility of respiratory muscle training (RMT) in patients with spinal muscular atrophy (SMA) and respiratory muscle weakness.
Design:
A 4-month, single-blinded RCT, followed by an 8-month extension phase.
Setting:
The outpatient clinic of the Neurology department and the Child Development and Exercise Center at the University Medical Center Utrecht, The Netherlands.
Participants:
30 participants, ≥eight years, SMA type 1 to 4, and respiratory muscle weakness.
Interventions:
The training group started RMT at 30% of their maximum inspiratory (PImax) and expiratory pressure (PEmax) and adjusted their training intensity based on perceived exertion. The control group started and continued RMT at 10% of PImax and PEmax. After four months, the control group received the same RMT as the training group.
Main Outcome Measures:
The primary outcome was the between-group difference in PImax after the RCT phase. Additionally, we explored the association between training volume (i.e., number of training sessions x training intensity) and increase in PImax over 1 year.
Results:
25 participants completed the study. Mean PImax after four months (corrected for baseline value) training group: 61.1 cmH2O, control group: 54.3 cmH2O, mean difference in PImax: 6.8 cmH2O [95% CI: -2.0 to 15.6]. Despite the study being underpowered, we did find an association between training volume and increase in PImax (R2 = 0.531).
Conclusion:
There was a small between-group difference in PImax after the RCT phase. The training was safe, but the feasibility of the training needs further improvement.
Clinical Trial Registration Number:
NL73280.041.20. CONTRIBUTION OF THE PAPER.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...

